Get the Stockscreener App
1.01
2.84%
-0.0295
After Hours:
1.00
-0.01
-0.99%
Biofrontera Inc stock is traded at $1.01, with a volume of 55,720.
It is down -2.84% in the last 24 hours and up +24.69% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$1.0395
Open:
$1.06
24h Volume:
55,720
Relative Volume:
0.28
Market Cap:
$10.24M
Revenue:
$34.07M
Net Income/Loss:
$-20.13M
P/E Ratio:
-0.0782
EPS:
-12.92
Net Cash Flow:
$-24.90M
1W Performance:
-0.98%
1M Performance:
+24.69%
6M Performance:
+50.52%
1Y Performance:
+11.17%
1-Day Range:
$1.00
$1.0696
1-Week Range:
$1.00
$1.09
52-Week Range:
$0.536
$2.22
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.01 | 11.09M | 34.07M | -20.13M | -24.90M | -12.92 |
|
ZTS
Zoetis Inc
|
143.49 | 63.27B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.31 | 45.67B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.04 | 39.27B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.21 | 23.02B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.93 | 20.66B | 3.08B | 1.24B | 1.07B | 25.61 |
Biofrontera Inc Stock (BFRI) Latest News
What analysts say about Biofrontera Inc Equity Warrant stockRisk Mitigation Techniques & High Return Market Tips - earlytimes.in
Biofrontera Inc. stock outlook for YEARPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com
Risk vs reward if holding onto Biofrontera Inc. Equity WarrantPortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
Top chart patterns to watch in Biofrontera Inc.2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Will Biofrontera Inc. stock recover after recent dropJuly 2025 Decliners & Verified Short-Term Plans - newser.com
What to do if you’re stuck in Biofrontera Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Biofrontera Inc. stock trendline breakdownPortfolio Return Report & High Yield Equity Trading Tips - newser.com
What data driven models say about Biofrontera Inc.’s futurePortfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Is Biofrontera Inc. stock a safe haven assetWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Biofrontera says last patient completes treatment in Phase 3 study of Ameluz - MSN
Benign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Its Share Price - simplywall.st
Benchmark Co. Reaffirms Their Buy Rating On Biofrontera (BFRI) - Barchart.com
Benchmark reiterates Buy rating on Biofrontera stock amid tariff concerns - Investing.com
Is Biofrontera Inc. stock dividend yield sustainableJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com
Why analysts remain bullish on Biofrontera Inc. Equity Warrant stockMarket Risk Analysis & AI Driven Price Predictions - newser.com
Biofrontera Inc. stock chart pattern explainedJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Biofrontera Inc. price target lowered to $9 from $10 at Roth Capital - TipRanks
What analysts say about Biofrontera Inc stockEarnings Volatility Patterns & Control Your Emotions With Discipline Tools - earlytimes.in
Correction notice regarding the H1 2025 report and the corresponding press release dated September 30, 2025, 00:18 a.m. - TradingView
What drives Biofrontera Inc stock priceDividend Growth Stocks & Free Phenomenal Investment Performance - earlytimes.in
Published on: 2025-09-30 04:07:09 - newser.com
Can Biofrontera Inc. Equity Warrant stock resist sector downturnsProfit Target & Accurate Intraday Trading Signals - newser.com
Volume spikes in Biofrontera Inc. Equity Warrant stock – what they meanWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
What drives Biofrontera Inc Equity Warrant stock priceSector Performance Drivers & High Return Trading Strategies - earlytimes.in
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST HALF OF 2025 - TradingView
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.54%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):